Sponsor Pipeline

SANGMYUNG innovation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07695207 Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular… Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy Recruiting
NCT07708142 Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular… Retinal Vein Occlusion With Macular Edema Recruiting
Get alerts when SANGMYUNG innovation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free